Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates.

Critical care (London, England)

Volumn 13, Issue 6, 2009, Pages

  Oudemans van Straaten, Heleen M ^a   van Schilfgaarde, Muriel ^a   Molenaar, Pascal J ^a   Wester, Jos Pj ^a   Leyte, Anja ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; THROMBIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; APACHE; ARTICLE; BLOOD CLOTTING; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CROSSOVER PROCEDURE; DRUG EFFECT; FEMALE; HEMOFILTRATION; HEMOSTASIS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

ADULT; AGED; ANTICOAGULANTS; APACHE; BLOOD COAGULATION; CRITICAL ILLNESS; CROSS-OVER STUDIES; FACTOR XA; FEMALE; HEMOFILTRATION; HEMOSTASIS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; NADROPARIN; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDIES; SEPSIS; SHOCK, CARDIOGENIC; THROMBIN;

MLCS; MLOWN;

EID: 77951629602     PISSN: None     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8191     Document Type: Article

References (0)